SenesTech, Inc. (SNES)

Market Cap	4.64M
Revenue (ttm)	824,000
Net Income (ttm)	-9.65M
Shares Out	12.21M
EPS (ttm)	-0.72
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	22,458
Open	0.354
Previous Close	0.368
Day's Range	0.337 - 0.429
52-Week Range	0.338 - 1.685
Beta	1.17
Analysts	Buy
Price Target	4.08 (+973.7%)
Earnings Date	Nov 8, 2022

About SNES

SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.

• Industry: Pharmaceuticals
• IPO Date: Dec 8, 2016
• CEO: Kenneth Siegel
• Employees: 26
• Stock Exchange: NASDAQ
• Ticker Symbol: SNES

Full Company Profile

Financial Performance

In 2021, SenesTech's revenue was $600,000, an increase of 112.77% compared to the previous year's $282,000. Losses were -$8.27 million, 4.17% more than in 2020.

Financial Statements

Analyst Forecast

According to 7 analysts, the average rating for SNES stock is "Buy." The 12-month stock price forecast is 4.08, which is an increase of 973.68% from the latest price.

Price Target

$4.08

(973.68% upside)

Analyst Consensus: Buy

Stock Forecasts